Deal-Breaking News

Showing posts with label Deal. Show all posts

Friday, December 11, 2015

Officials race to finish global climate change deal

Tuesday, December 8, 2015

Interpublic Acquires Russian Advertising Agencies in Long-Sought Deal

Interpublic Group of Companies, which is based in New York, has done business in Russia for two decades through ADV and will now directly own three agencies of its longtime partner.

Saturday, December 5, 2015

Samardzija Agrees to $90 Million, 5-Year Deal With Giants

Samardzija Agrees to Million, 5-Year Deal With Giants

The San Francisco Giants landed a top-tier starter to complement ace Madison Bumgarner, agreeing with free agent Jeff Samardzija on a $ 90 million, five-year contract Saturday a day after losing out on Zack Greinke.

Thursday, November 26, 2015

Barclays Fined for Lax Crime Checks in ‘Deal of Century’

Britain’s financial watchdog has fined Barclays 72 million pounds, or nearly $ 109 million, for cutting corners in checking wealthy customers involved in a huge transaction.

Wednesday, November 25, 2015

Tech Fix: Black Friday Deal or Dud? How to Shop Smart This Holiday Season

Only a small fraction of Black Friday discounts are true bargains, according to the editor of The Wirecutter, a product recommendation site. But there’s a way to check which purchases are worthwhile.

Tuesday, November 24, 2015

Why Pfizer’s Deal May Change the System of Taxing Multinationals

The United States approach has been a failure, and a $ 152 billion drug merger could nudge tax-writing committees in Washington into action.

News: Morning Agenda: Pfizer-Allergan Deal Revives Debate Over U.S. Taxes

Elliott Adds a Chief Executive | Ackman Raises Stake in Valeant | Diller’s Minifactory of Spinoffs Pays Off

Monday, November 23, 2015

Pfizer to Merge With Allergan in $160 Billion Deal

Pfizer to Merge With Allergan in 0 Billion Deal

The agreement would be the latest, and largest, aimed at helping an American company lower its taxes by reincorporating overseas, a tactic known as corporate inversion.

Pfizer to Merge With Allergan in $160 Billion Deal

Pfizer to Merge With Allergan in 0 Billion Deal

The agreement would be the latest, and largest, aimed at helping an American company lower its taxes by reincorporating overseas, a tactic known as corporate inversion.